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Surgical repair of aortic aneurysms involving the visceral arteries carries high morbidity and mortality in poor surgical
candidates. With current technology, visceral artery involvement generally precludes endovascular repair of aortic
aneurysms. We report on a patient with a large abdominal aortic pseudoaneurysm involving the origin of the superior
mesenteric artery. This aneurysm was successfully repaired by transluminal thrombin injection of the sac and exclusion
with balloon expandable covered stents placed in the aorta. (J Vasc Surg 2004;39:1118-21.)The surgical treatment of aneurysms confined to the
suprarenal abdominal aorta requires an extensive surgical
exposure and supraceliac aortic clamping. This magnitude
of surgery is not well tolerated by patients with major
comorbidities and may not be advisable in patients with
limited life expectancy. Under these circumstances, a less
invasive approach is advisable. Anecdotal experience with
covered stents, fenestrated covered stents, branched en-
dografts, and embolotherapy with or without a combined
surgical procedure has been reported. Currently, only an-
eurysms with favorable anatomic features are amenable to
endoluminal repair. The present case describes the use of
transluminal thrombin injection and covered stents to
thrombose and exclude a large pseudoaneurysm arising
adjacent to the orifice of the superior mesenteric artery
(SMA) and just distal to the celiac artery.
CASE REPORT
A 68-year-old man with severe emphysema and coronary
artery disease was found during evaluation for a pulmonary nodule
to have a 5-cm aortic pseudoaneurysm (PA) arising between the
origins of the celiac and renal arteries (Figs 1 and 2). The patient
had had bacterial endocarditis three months before, and had
undergone an aortobifemoral bypass 3 years earlier for claudica-
tion.
The patient had been afebrile for over two months, had
negative blood cultures, a normal leukocyte count, and a slightly
elevated sedimentation rate, and no valve vegetations were seen on
echocardiogram. Therefore, we believed that the patient was not
septic and the PA was not infected. An angiogram revealed that the
PA originated between the celiac and the renal arteries, involving
the SMA origin, with proximal occlusion and distal reconstitution
of the SMA. The aortobifemoral bypass graft was patent, and its
proximal anastomosis was not related to the PA. The computed
tomography (CT) scan revealed that the origin and proximal SMA
were compressed by the PA arising from the more proximal aorta,
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doi:10.1016/j.jvs.2003.12.0341118and that there was no inflammation around the PA, with no
suggestion of infection. Therefore, given the patient’s comorbidi-
ties, endoluminal treatment was recommended because it was felt
to be a lower-risk option that open repair. Angiography and CT
scan measurements showed short landing zones (1 cm) between
the PA neck and the celiac artery proximally and slightly longer
proximal to the renal arteries.
Perioperative intravenous antibiotics were given for subacute
bacterial endocarditis prophylaxis. During surgery, the right limb
of the aortobifemoral graft was exposed in the groin, and percuta-
neous access was gained to the left. In addition, the right brachial
artery was cannulated to allow antegrade access to the celiac artery
(the left arm had diminished pulses). A 4-cm-long balloon-
expandable stent (Palmaz XL P4010, Cordis, Jonhson & Johnson
Co. Piscataway, NJ) was covered with polytetrafluoroethylene
expanded to 25 mm, and was mounted on a 25  40-mm
angioplasty balloon. The patient was heparinized. Under fluoros-
copy, a 5 French selective visceral catheter was placed over a
guidewire through the left femoral sheath into the PA sac and a
bare 4 25  40-mm angioplasty balloon was placed in the aorta
through the right femoral sheath, and inflated across the origin of
the PA neck. To prevent thrombin spillage, a small volume of
contrast was injected into the sac to ascertain its seal, and then
aspirated (Fig 2, left) After aspiration of 4 mL of blood, 4000 units
of bovine thrombin in a 4-ml solution were injected into the sac
through the visceral catheter. This produced extensive thrombosis
of the sac, but a small amount of flow persisted (Fig 2, right). After
removal of the visceral catheter and aortic balloon, the covered
stent was deployed through a 22 French valved sheath (Keller-
Timmermans introducer, Cook Inc, Bloomington, Ind) between
the celiac and renal arteries. An angiogram visualized a small
residual proximal endoleak. This was corrected by deploying an
additional covered stent slightly proximal to the initial one, just
distal to the celiac artery origin. A completion angiogram demon-
strated complete exclusion of the PA, but absence of flow into the
celiac artery. It was apparent that the aortic stents had displaced the
PA anteriosuperiorly, and that the PA in turn was pushing the
celiac artery upwards. To correct this, a 6  40-mm balloon-
expandable stent was deployed in the celiac artery, restoring its
patency (Fig 3).
Following surgery, the creatinine remained normal and there
were no abdominal problems. The patient was discharged from the
hospital on the second postoperative day. Two weeks later, the
patient underwent a curative lung resection for cancer. Six months
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Volume 39, Number 5 Criado and Gasparis 1119Fig 1. CT scan with contrast demonstrating a large aortic pseudoaneurysm arising at the level of the superior
mesenteric artery (left) and three-dimensional CT reconstruction (right) showing the perivisceral origin of the
pseudoaneurysm encroaching the superior mesenteric artery, and the proximity of the celiac and renal arteries.Fig 2. Left, Contrast injection into the pseudoaneurysm sac through a selective visceral catheter with an inflated aortic
balloon in place. It denotes that the sac is sealed from the aortic flow allowing safe injection of thrombin. Right,
Angiogram following thrombin injection and removal of the aortic balloon. It demonstrates residual flow into the sac
(arrow) and the upwards displacement of the celiac artery by the pseudoaneurysm.
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demonstrated PA resolution with no evidence of endoleak.
DISCUSSION
Percutaneous thrombin injection has become an estab-
lished treatment for iatrogenic femoral pseudoaneurysms.
However, the use of transluminal thrombin injection of
aortic lesions remains anecdotal. Successful translumbar
injection of a perforated aortic ulcer and of a sac endoleak
following endovascular repair has been reported.1,2 Trans-
luminal thrombin injection of an aortic PA, however, has
been associated with potentially lethal thrombus propaga-
tion.3 To prevent this complication during thrombin injec-
tion, we occluded flow into the PA sac by inflating a balloon
across the aortic orifice. This technique is safer than percu-
taneous injection, in which the PA remains in contact with
the aortic flow during thrombin injection. In cases in which
PA rupture is possible during instrumentation, the
transaortic balloon serves additionally as a safeguard to
occlude the aorta and control bleeding while additional
treatment is devised.
Fig 3. Angiogram following deployment of two covered stents
distal to the celiac origin and proximal to the renal arteries, and of
a balloon-expandable stent in the proximal celiac artery. Good
opacification of the celiac and renal arteries is demonstrated.When the origins of the visceral vessels are not involved
by the aneurysm, a fenestrated endograft is an option. This
was technically feasible in a case where the aortic pseudo-
aneurysm originated in the posterior aspect of the aorta,
allowing the fenestrated portion of the endograft to face
anteriorly against the visceral arteries while the non-fenes-
trated portion obliterated the PA neck.4 Rather than using
a commercially available aortic cuff, we opted to use a
handmade balloon-expandable, fully covered stent be-
cause, in our experience, it provides greater precision dur-
ing deployment and gives a tighter fit in the aorta, perhaps
decreasing the risk of endoleak. Precision during delivery
was particularly important in this case because of the limited
space for additional stenting distal to the celiac artery. We
believe that the combination of a balloon-expandable cov-
ered stent with thrombin injection of the sac was the best
choice to produce aneurysm exclusion and thrombosis with
a single procedure.
The complexity and potential complications of these
procedures, however, is illustrated in Madhavan’s5 report
of a suprarenal mycotic aortic aneurysm treated with a
combined approach using a stent partially covered with
autogenous iliac artery deployed through an infrarenal
aortotomy. The procedure was complicated by renal fail-
ure, paraplegia, and ischemic colitis, sparing none of the
major complications of suprarenal aortic surgery. Visceral
ischemia did not developed in our patient perhaps because
the celiac artery was occluded for only a few minutes. In
anticipation of this problem, we attempted to place a wire
in the celiac artery orifice prior to covered stent deploy-
ment, but we desisted because of technical difficulty, finally
accessing the celiac artery from the groin.
When visceral arterial perfusion cannot be maintained
by endovascular means, a combined open visceral bypass
followed by aortic endografting across the visceral orifices is
a reasonable alternative.6 This combined approach may
provide a better chance for uneventful recovery and long-
term survival in patients poorly suited for a supraceliac open
procedure. Our case was unique in this regard, because the
SMA was already chronically occluded. Therefore, we did
not need to preserve its patency.
The use of a branched endograft deployed in the renal
and the superior mesenteric arteries has been reported for
the exclusion of a suprarenal abdominal aneurysm adjacent
to the orifice of the SMA.7 However, to date, these
branched grafts are not available, and their reliability in
maintaining long-term perfusion of the visceral and renal
arteries remains unproven.
In summary, our case illustrates how thrombin injec-
tion of a perivisceral aortic pseudoaneurysm can be safely
done with aortic balloon occlusion across the PA orifice. In
addition, using currently available commercial products, an
endovascular graft can be custom constructed for deploy-
ment across or adjacent to the visceral vessels for the
exclusion of paravisceral aortic pseudoaneurysms. This
technique in combination with a visceral artery bypass can
widely expand the applicability of endovascular exclusion of
aneurysms confined to the suprarenal abdominal aorta, and
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These endovascular procedures require detailed preopera-
tive imaging and knowledge on the construction and deliv-
ery of custom-made endovascular devices.
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